Showing results (81-90 of 343) with videos related to
Sort By:
Pageof 35
The Lancet. Gastroenterology & Hepatology|May 7, 2021
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approachGiovanni Targher, Herbert Tilg, Christopher D ByrneGut|April 24, 2020
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implicationsGiovanni Targher, Christopher D Byrne, Herbert TilgNature Reviews. Gastroenterology & Hepatology|November 28, 2018
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targetingAlexander R Moschen, Herbert Tilg, Tim RaineArchivum Immunologiae Et Therapiae Experimentalis|January 12, 2013
Inflammation, cytokines and insulin resistance: a clinical perspectiveVerena Wieser, Alexander R Moschen, Herbert TilgDigestive Diseases (Basel, Switzerland)|October 31, 2012
Adipocytokines and hepatocellular carcinomaVerena Wieser, Alexander R Moschen, Herbert TilgThe Lancet. Gastroenterology & Hepatology|August 19, 2023
NASH drug treatment development: challenges and lessonsHerbert Tilg, Christopher D Byrne, Giovanni TargherGut|July 24, 2020
Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humansChristoph Grander, Benedikt Schaefer, Julian Schwärzler, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 13, 2006
How to modulate inflammatory cytokines in liver diseasesHerbert Tilg, Arthur Kaser, Alexander R MoschenTrends in Endocrinology and Metabolism: TEM|July 6, 2013
Non-alcoholic steatohepatitis: a microbiota-driven diseaseAlexander R Moschen, Susanne Kaser, Herbert TilgGut|January 16, 2024
MASLD: a systemic metabolic disorder with cardiovascular and malignant complicationsGiovanni Targher, Christopher D Byrne, Herbert TilgPageof 35